Commentary: Management Strategies for POSEIDON Groups 3 and 4.
作者信息
Bühler Klaus F
机构信息
Department of Gynaecology, University Hospital Jena, Jena, Germany.
出版信息
Front Endocrinol (Lausanne). 2020 Jan 24;10:920. doi: 10.3389/fendo.2019.00920. eCollection 2019.
Abstract
摘要
相似文献
1
Commentary: Management Strategies for POSEIDON Groups 3 and 4.评论：POSEIDON 3组和4组的管理策略
Front Endocrinol (Lausanne). 2020 Jan 24;10:920. doi: 10.3389/fendo.2019.00920. eCollection 2019.
2
An Observational Retrospective Cohort Trial on 4,828 IVF Cycles Evaluating Different Low Prognosis Patients Following the POSEIDON Criteria.一项针对4828个体外受精周期的观察性回顾性队列试验，根据POSEIDON标准评估不同低预后患者。
Front Endocrinol (Lausanne). 2019 May 8;10:282. doi: 10.3389/fendo.2019.00282. eCollection 2019.
3
Inhibin and estradiol alter gonadotropes differentially in ovine pituitary cultures: changing gonadotrope numbers and calcium responses to gonadotropin-releasing hormone.抑制素和雌二醇对绵羊垂体培养物中的促性腺激素细胞有不同影响：改变促性腺激素细胞数量以及对促性腺激素释放激素的钙反应。
Endocrinology. 1996 Nov;137(11):5144-54. doi: 10.1210/endo.137.11.8895389.
4
Ovarian Reserve Markers to Identify Poor Responders in the Context of Poseidon Classification.在波塞冬分类背景下用于识别低反应者的卵巢储备标志物
Front Endocrinol (Lausanne). 2019 May 8;10:281. doi: 10.3389/fendo.2019.00281. eCollection 2019.
5
Regulation and action of gonadotrophins in pigs.
J Reprod Fertil Suppl. 1990;40:19-32.
6
Androgens Profile in Blood Serum and Follicular Fluid of Women With Poor Ovarian Response During Controlled Ovarian Stimulation Reveals Differences Amongst POSEIDON Stratification Groups: A Pilot Study.控制性卵巢刺激过程中卵巢反应不良女性血清和卵泡液中的雄激素谱揭示了波塞冬分层组之间的差异：一项初步研究。
Front Endocrinol (Lausanne). 2019 Jul 16;10:458. doi: 10.3389/fendo.2019.00458. eCollection 2019.
7
In vitro basal and GnRH-stimulated secretion of gonadotrophins reflects long-lasting modulatory effects, and peripheral levels are not predicted by pituitary responsiveness to GnRH.体外促性腺激素的基础分泌和GnRH刺激分泌反映了长期的调节作用，垂体对GnRH的反应性无法预测外周水平。
Eur J Endocrinol. 1999 Nov;141(5):512-20. doi: 10.1530/eje.0.1410512.
8
Daily administration of gonadotrophin-releasing hormone increases pituitary gonadotroph number and pituitary gonadotrophin content, but not serum gonadotrophin levels, in female rats on day 1 of dioestrus.
J Endocrinol. 1992 Mar;132(3):395-400. doi: 10.1677/joe.0.1320395.
9
Recombinant LH supplementation to a standard GnRH antagonist protocol in women of 35 years or older undergoing IVF/ICSI: a randomized controlled multicentre study.35 岁及以上接受 IVF/ICSI 的女性中，重组 LH 补充到标准 GnRH 拮抗剂方案中：一项随机对照多中心研究。
Hum Reprod. 2013 Oct;28(10):2804-12. doi: 10.1093/humrep/det266. Epub 2013 Jul 9.
10
Differential secretion of gonadotrophins: investigation of the role of secretogranin II and chromogranin A in the release of LH and FSH in LbetaT2 cells.促性腺激素的差异性分泌：分泌粒蛋白II和嗜铬粒蛋白A在LbetaT2细胞中促黄体生成素和促卵泡生成素释放中的作用研究
J Mol Endocrinol. 2004 Apr;32(2):467-80. doi: 10.1677/jme.0.0320467.
引用本文的文献
1
Improving Reporting of Clinical Studies Using the POSEIDON Criteria: POSORT Guidelines.使用 POSEIDON 标准提高临床研究报告质量：POSORT 指南。
Front Endocrinol (Lausanne). 2021 Mar 19;12:587051. doi: 10.3389/fendo.2021.587051. eCollection 2021.
2
Cumulative live birth rates of patients in the Peruvian Andes according to the POSEIDON criteria: a single-center retrospective analysis.根据 POSEIDON 标准，秘鲁安第斯地区患者的累积活产率：一项单中心回顾性分析。
JBRA Assist Reprod. 2021 Jul 21;25(3):412-416. doi: 10.5935/1518-0557.20200107.
本文引用的文献
1
Management Strategies for POSEIDON Groups 3 and 4.波塞冬3组和4组的管理策略
Front Endocrinol (Lausanne). 2019 Sep 11;10:614. doi: 10.3389/fendo.2019.00614. eCollection 2019.
2
Defining Low Prognosis Patients Undergoing Assisted Reproductive Technology: POSEIDON Criteria-The Why.界定接受辅助生殖技术的低预后患者：POSEIDON标准——原因
Front Endocrinol (Lausanne). 2018 Aug 17;9:461. doi: 10.3389/fendo.2018.00461. eCollection 2018.
3
Clinical relevance of genetic variants of gonadotrophins and their receptors in controlled ovarian stimulation: a systematic review and meta-analysis.促性腺激素及其受体的遗传变异在控制性卵巢刺激中的临床相关性：系统评价和荟萃分析。
Hum Reprod Update. 2018 Sep 1;24(5):599-614. doi: 10.1093/humupd/dmy019.
4
The effect on clinical results of adding recombinant LH in late phase of ovarian stimulation of patients with repeated implantation failure: a pilot study.添加重组 LH 对反复着床失败患者卵巢刺激晚期临床结局的影响：一项初步研究。
Eur Rev Med Pharmacol Sci. 2017 Dec;21(23):5485-5490. doi: 10.26355/eurrev_201712_13939.
5
Serum and follicular fluid testosterone concentrations do not correlate, questioning the impact of androgen supplementation on the follicular endocrine milieu.血清和卵泡液中的睾酮浓度并不相关，这质疑了雄激素补充对卵泡内分泌环境的影响。
Reprod Biomed Online. 2017 Nov;35(5):616-623. doi: 10.1016/j.rbmo.2017.07.012. Epub 2017 Aug 2.
6
LH pretreatment as a novel strategy for poor responders.促黄体生成素预处理作为一种针对低反应者的新策略。
Biomed Res Int. 2014;2014:926172. doi: 10.1155/2014/926172. Epub 2014 Aug 12.
7
Accumulation of oocytes: a new strategy for managing low-responder patients.卵母细胞积累：一种管理低反应患者的新策略。
Reprod Biomed Online. 2012 Apr;24(4):424-32. doi: 10.1016/j.rbmo.2011.12.012. Epub 2012 Jan 8.
8
Recombinant human LH supplementation versus supplementation with urinary hCG-based LH activity during controlled ovarian stimulation in the long GnRH-agonist protocol: a matched case-control study.在长 GnRH 激动剂方案中控制性卵巢刺激期间，重组人 LH 补充与基于尿 hCG 的 LH 活性补充相比：一项匹配病例对照研究。
Gynecol Endocrinol. 2012 May;28(5):345-50. doi: 10.3109/09513590.2011.633128. Epub 2011 Nov 24.
9
A systematic review of randomized trials for the treatment of poor ovarian responders: is there any light at the end of the tunnel?一项针对卵巢反应不良患者治疗的随机试验的系统评价：隧道尽头是否有光？
Fertil Steril. 2011 Nov;96(5):1058-61.e7. doi: 10.1016/j.fertnstert.2011.09.048.
10
ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria.ESHRE 共识：体外受精卵巢刺激反应不良的定义：博洛尼亚标准。
Hum Reprod. 2011 Jul;26(7):1616-24. doi: 10.1093/humrep/der092. Epub 2011 Apr 19.
Zotero 插件